1. Yadav T, Singh S, Singh J et al (2018) Demographic profile and real world data of persons with haemophilia (PWH) in a resource constrained setup. Indian J Hematol Blood Transfus 34(Suppl 1):S137
2. Chakraborty J, Bhattacharyya M, Ray SS (2018) Effect of low dose prophylaxis versus episodic treatment on joint events in severe hemophilia A patients above 2 years: a randomized open label pilot study in eastern India. Indian J Hematol Blood Transfus 34(Suppl 1):S68
3. Yadav N, Sharma S, Satyanand K et al (2018) Low dose secondary and tertiary prophylaxis in severe hemophilia A reduces bleeding rates. Indian J Hematol Blood Transfus 34(Suppl 1):S134
4. Kolla R, Brand-Stauffer B, Dahl PW et al (2018) Turoctocog alfa is stable during storage at 40°C and multiple sequences of temperature cycling. Indian J Hematol Blood Transfus 34(Suppl 1):S125
5. Joshi AD, Kannan S, Patel D et al (2018) Pharmacokinetic study of factor infusion in haemophilia Aand B patients who underwent surgery: a single centre experience from western India. Indian J Hematol Blood Transfus 34(Suppl 1):S143